Daily Current Affairs / DCGI approves two clinical trials of indigenous Covid vaccine Corbevax
Category : National Published on: September 04 2021
· The Drug Controller General of India- DCGI has approved two clinical trials of indigenous Covid vaccine Corbevax.
· Vaccine maker Biologicals E has received permission for Phase II and III trials on children between the ages of five and eighteen under certain conditions.
· The Department of Biotechnology and its PSU Biotechnology Industry Research Assistance Council – BIRAC have provided support to Biologicals E's COVID-19 Vaccine.
· This support will be provided from the preclinical phase to the third phase of the trial.
Important facts
About the DCGI
v DCGI: Drugs Controller General of India
v Headquarters location: New Delhi
‘AI for Good – Impact India Summit 2025’ showcased India’s leadership in using Artificial Intelligence for sustainable development and ethical digital growth.
Read More....Union Minister Shri Sarbananda Sonowal, along with Assam Chief Minister Dr. Himanta Biswa Sarma, distributed capital assistance under the “Mukhyamantri Mahila Udyamita Abhiyan” in Dibrugarh.
Read More....Prime Minister Shri Narendra Modi inaugurated the “Pradhan Mantri Dhan-Dhanya Kisan Yojana” and “Dalhan Atmanirbhar Mission” in Pusa, Delhi.
Read More....Sugamya Bharat App launched at Purple Fest to empower persons with disabilities and promote inclusive access.
Read More....Three major Indian ports:- Deendayal, V.O. Chidambaranar and Paradip designated as Green Hydrogen Hubs to boost India’s clean energy transition.
Read More....India and the UK launch the Connectivity & Innovation Centre to advance secure, innovative telecom and digital inclusion.
Read More....
